Alphatec Holdings Performance Comparison

Loading chart data...

Stock Range

Today's Range

Low: $15.78 High: $16.07
on August 21, 2025

52 Week Range

Low: $4.88 High: $16.07
on October 10, 2024
on August 21, 2025

All-Time High: $105.60 on June 12, 2006

Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights

Key Statistics

Market Cap i $2.3B
EPS i -1.13
P/E Ratio (TTM) i -13.98
Forward P/E i -24.15
P/B Ratio i 96.91
PEG Ratio i 2.03
Div. Yield i N/A
ROE i -376.89%
Beta i 1.054
Debt to Equity i 1,238.29

Financial Highlights

Profitability

Gross Margin i 69.58%
Operating Margin i -6.19%
Profit Margin i -24.33%

Returns and Earnings

Return on Assets (TTM) i -7.61%
Return on Equity (TTM) i -376.89%
EBITDA i $-15.0M
Net Income (TTM) i $-166.0M

Growth

Revenue (TTM) i
Revenue Per Share (TTM) i $4.73
Quarterly Revenue Growth (YoY) i 27.50%
Quarterly Earnings Growth (YoY) i 27.46%

Peer Performance Comparison

Performance comparison table showing returns for peer companies over various time periods
CompanyMarket Cap1W1M3M6MYTD1Y3Y5Y
Alphatec Holdings ATEC 2.32B Mid-cap2.31%54.51%25.83%50.14%75.83%177.53%103.45%165.94%
Abbott Laboratories ABT 229.31B Mega-cap2.10%6.09%-0.79%-2.16%16.36%17.14%29.54%19.14%
Boston Scientific BSX 153.73B Large-cap1.02%1.38%0.54%0.69%17.71%32.89%159.65%156.42%
Penumbra PEN 9.87B Mid-cap-0.73%9.84%-7.03%-13.82%4.74%19.63%51.55%13.77%
Globus Medical GMED 8.26B Mid-cap0.80%16.59%2.06%-24.64%-26.07%-16.03%0.27%7.14%
Masimo MASI 7.97B Mid-cap-5.02%-7.02%-3.45%-15.13%-14.43%20.26%-4.97%-34.37%

Ownership & Short Interest

Insider Ownership i 21.04%
Institutional Ownership i 69.05%
Shares Short i 13M
Short Ratio i 8.50
Short % of Shares Outstanding i 10.39%
Average 10-Day Volume i 3M
Average 90-Day Volume i 3M

Alphatec Holdings Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Alphatec Holdings would have performed over time.

$
If not specified, the latest available data will be used

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

In the last 52 weeks, Alphatec Holdings reached a high of $16.07 (on August 21, 2025) and a low of $4.88 (on October 10, 2024).
Curious about Alphatec Holdings's size and valuation? Its market capitalization stands at 2.32B. When it comes to valuation, the P/E ratio (trailing twelve months) is -13.98, and the forward P/E (looking ahead) is -24.15.
As for dividends, Alphatec Holdings isn't currently offering a significant yield, or that specific data isn't available right now.

When looking at Alphatec Holdings, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

CompanyMkt CapSectorIndustry1Y Return3Y Return
Abbott Laboratories
ABT
229.31BHealthcareMedical Devices17.14%29.54%
Boston Scientific
BSX
153.73BHealthcareMedical Devices32.89%159.65%
Penumbra
PEN
9.87BHealthcareMedical Devices19.63%51.55%
Globus Medical
GMED
8.26BHealthcareMedical Devices-16.03%0.27%
Masimo
MASI
7.97BHealthcareMedical Devices20.26%-4.97%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

To get a sense of Alphatec Holdings's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -376.89%, the Debt to Equity ratio from the most recent quarter is 1,238.29, and its Gross Profit Margin stands at 69.58%.
Looking at Alphatec Holdings's growth, its revenue over the trailing twelve months (TTM) was $682M. Compared to the same quarter last year (YoY), quarterly revenue grew by 27.50%, and quarterly earnings saw a YoY growth of 27.46%.
Wondering who owns Alphatec Holdings stock? Company insiders (like executives and directors) hold about 21.04% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 69.05%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.